Virtu Financial’s Microbot Medical MBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-40,042
Closed -$96K 1973
2026
Q1
$96K Sell
40,042
-18,632
-32% -$41.6K ﹤0.01% 1199
2025
Q4
$117K Buy
+58,674
New +$139K ﹤0.01% 1170
2025
Q2
Sell
-27,655
Closed -$42K 1805
2025
Q1
$42K Buy
+27,655
New +$48.9K ﹤0.01% 1030
2024
Q3
Sell
-13,379
Closed -$14K 1670
2024
Q2
$14K Buy
+13,379
New +$13.8K ﹤0.01% 1081
2024
Q1
Sell
-42,046
Closed -$69K 1798
2023
Q4
$69K Buy
42,046
+18,138
+76% +$24.2K 0.01% 1116
2023
Q3
$33K Buy
+23,908
New +$51.9K ﹤0.01% 947
2022
Q1
Sell
-12,622
Closed -$95K 1799
2021
Q4
$95K Buy
+12,622
New +$81.3K 0.01% 1150
2019
Q4
$606K Buy
+59,598
New +$349K 0.06% 348
2018
Q3
Sell
-5,139
Closed -$57K 1929
2018
Q2
$57K Buy
+5,139
New +$62.6K ﹤0.01% 1736

Other funds holding MBOT

Virtu Financial's MBOT Position: Q2 2026 in Review

Virtu Financial sold out of Microbot Medical (MBOT) in Q2 2026, closing a stake of 40,042 shares — an estimated $96K sold.

Virtu Financial first reported a position in MBOT in Q2 2018 and held it in 9 quarters. The position peaked at $606K in Q4 2019. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Virtu Financial reported no remaining Microbot Medical position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 40,042 Microbot Medical shares in Q2 2026, an estimated $96K.
  • Virtu Financial first reported a position in Microbot Medical in Q2 2018 and held it in 9 quarters.
  • Virtu Financial's Microbot Medical position peaked at $606K in Q4 2019.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.